SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,387,651 | -4.4% | 159,146 | +4.3% | 0.09% | -14.2% |
| Q2 2023 | $4,588,476 | -16.4% | 152,644 | +0.8% | 0.11% | -19.7% |
| Q1 2023 | $5,486,596 | +14.8% | 151,438 | +13.1% | 0.13% | +7.3% |
| Q4 2022 | $4,778,065 | +2.6% | 133,952 | -2.6% | 0.12% | -2.4% |
| Q3 2022 | $4,657,000 | +16.1% | 137,596 | -0.8% | 0.13% | +23.5% |
| Q2 2022 | $4,012,000 | -13.1% | 138,734 | -2.9% | 0.10% | +1.0% |
| Q1 2022 | $4,617,000 | +39.1% | 142,845 | +25.5% | 0.10% | +53.0% |
| Q4 2021 | $3,319,000 | – | 113,846 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |